HOLOGIC INC (HOLX) Stock Fundamental Analysis
NASDAQ:HOLX - Nasdaq - US4364401012 - Common Stock - Currency: USD
Overall HOLX gets a fundamental rating of 6 out of 10. We evaluated HOLX against 187 industry peers in the Health Care Equipment & Supplies industry. HOLX gets an excellent profitability rating and is at the same time showing great financial health properties. A decent growth rate in combination with a cheap valuation! Better keep an eye on HOLX. These ratings would make HOLX suitable for value investing!
1. Profitability
1.1 Basic Checks
In the past year HOLX was profitable.
In the past year HOLX had a positive cash flow from operations.
Each year in the past 5 years HOLX has been profitable.
In the past 5 years HOLX always reported a positive cash flow from operatings.
1.2 Ratios
HOLX has a better Return On Assets (6.33%) than 87.17% of its industry peers.
The Return On Equity of HOLX (11.50%) is better than 87.17% of its industry peers.
HOLX has a better Return On Invested Capital (10.03%) than 91.98% of its industry peers.
HOLX had an Average Return On Invested Capital over the past 3 years of 11.66%. This is above the industry average of 8.24%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.33% | ||
| ROE | 11.5% | ||
| ROIC | 10.03% |
ROA(3y)9.32%
ROA(5y)12.89%
ROE(3y)17.06%
ROE(5y)27.35%
ROIC(3y)11.66%
ROIC(5y)15.25%
1.3 Margins
HOLX's Profit Margin of 13.79% is amongst the best of the industry. HOLX outperforms 90.91% of its industry peers.
In the last couple of years the Profit Margin of HOLX has declined.
Looking at the Operating Margin, with a value of 24.55%, HOLX belongs to the top of the industry, outperforming 94.12% of the companies in the same industry.
In the last couple of years the Operating Margin of HOLX has grown nicely.
HOLX's Gross Margin of 56.34% is in line compared to the rest of the industry. HOLX outperforms 54.55% of its industry peers.
In the last couple of years the Gross Margin of HOLX has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 24.55% | ||
| PM (TTM) | 13.79% | ||
| GM | 56.34% |
OM growth 3Y-18.26%
OM growth 5Y7.36%
PM growth 3Y-16.15%
PM growth 5YN/A
GM growth 3Y-5.85%
GM growth 5Y1.6%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so HOLX is still creating some value.
HOLX has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, HOLX has less shares outstanding
HOLX has a better debt/assets ratio than last year.
2.2 Solvency
HOLX has an Altman-Z score of 3.97. This indicates that HOLX is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of HOLX (3.97) is better than 74.87% of its industry peers.
The Debt to FCF ratio of HOLX is 2.75, which is a good value as it means it would take HOLX, 2.75 years of fcf income to pay off all of its debts.
HOLX's Debt to FCF ratio of 2.75 is amongst the best of the industry. HOLX outperforms 88.77% of its industry peers.
HOLX has a Debt/Equity ratio of 0.52. This is a neutral value indicating HOLX is somewhat dependend on debt financing.
HOLX has a Debt to Equity ratio of 0.52. This is in the lower half of the industry: HOLX underperforms 62.03% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.52 | ||
| Debt/FCF | 2.75 | ||
| Altman-Z | 3.97 |
ROIC/WACC1.25
WACC8.04%
2.3 Liquidity
HOLX has a Current Ratio of 3.55. This indicates that HOLX is financially healthy and has no problem in meeting its short term obligations.
HOLX has a Current ratio of 3.55. This is in the better half of the industry: HOLX outperforms 63.10% of its industry peers.
A Quick Ratio of 2.81 indicates that HOLX has no problem at all paying its short term obligations.
With a decent Quick ratio value of 2.81, HOLX is doing good in the industry, outperforming 63.64% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.55 | ||
| Quick Ratio | 2.81 |
3. Growth
3.1 Past
HOLX shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 4.80%.
Measured over the past years, HOLX shows a quite strong growth in Earnings Per Share. The EPS has been growing by 10.83% on average per year.
The Revenue has been growing slightly by 1.29% in the past year.
Measured over the past years, HOLX shows a small growth in Revenue. The Revenue has been growing by 3.66% on average per year.
EPS 1Y (TTM)4.8%
EPS 3Y-21.36%
EPS 5Y10.83%
EPS Q2Q%1.89%
Revenue 1Y (TTM)1.29%
Revenue growth 3Y-10.56%
Revenue growth 5Y3.66%
Sales Q2Q%1.23%
3.2 Future
Based on estimates for the next years, HOLX will show a small growth in Earnings Per Share. The EPS will grow by 5.71% on average per year.
The Revenue is expected to grow by 4.75% on average over the next years.
EPS Next Y4.54%
EPS Next 2Y6.23%
EPS Next 3Y7.63%
EPS Next 5Y5.71%
Revenue Next Year1.37%
Revenue Next 2Y3.11%
Revenue Next 3Y3.83%
Revenue Next 5Y4.75%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 16.24, HOLX is valued correctly.
83.42% of the companies in the same industry are more expensive than HOLX, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of HOLX to the average of the S&P500 Index (27.03), we can say HOLX is valued slightly cheaper.
A Price/Forward Earnings ratio of 14.64 indicates a correct valuation of HOLX.
85.56% of the companies in the same industry are more expensive than HOLX, based on the Price/Forward Earnings ratio.
HOLX is valuated cheaply when we compare the Price/Forward Earnings ratio to 36.28, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.24 | ||
| Fwd PE | 14.64 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, HOLX is valued cheaper than 85.56% of the companies in the same industry.
HOLX's Price/Free Cash Flow ratio is rather cheap when compared to the industry. HOLX is cheaper than 88.77% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.38 | ||
| EV/EBITDA | 12.14 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates HOLX does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of HOLX may justify a higher PE ratio.
PEG (NY)3.57
PEG (5Y)1.5
EPS Next 2Y6.23%
EPS Next 3Y7.63%
5. Dividend
5.1 Amount
HOLX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:HOLX (8/6/2025, 2:11:54 PM)
67.38
-0.44 (-0.65%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners102.68%
Inst Owner Change-0.39%
Ins Owners0.78%
Ins Owner Change0.4%
Market Cap15.02B
Analysts71.43
Price Target72.77 (8%)
Short Float %2.33%
Short Ratio1.83
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.06%
Min EPS beat(2)-0.63%
Max EPS beat(2)0.76%
EPS beat(4)1
Avg EPS beat(4)-0.69%
Min EPS beat(4)-2.26%
Max EPS beat(4)0.76%
EPS beat(8)5
Avg EPS beat(8)0.96%
EPS beat(12)9
Avg EPS beat(12)5.99%
EPS beat(16)13
Avg EPS beat(16)15.79%
Revenue beat(2)0
Avg Revenue beat(2)-0.83%
Min Revenue beat(2)-1.44%
Max Revenue beat(2)-0.21%
Revenue beat(4)0
Avg Revenue beat(4)-1.18%
Min Revenue beat(4)-2.22%
Max Revenue beat(4)-0.21%
Revenue beat(8)1
Avg Revenue beat(8)-0.83%
Revenue beat(12)5
Avg Revenue beat(12)0.96%
Revenue beat(16)9
Avg Revenue beat(16)4.67%
PT rev (1m)2.79%
PT rev (3m)-9.58%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-4.12%
EPS NY rev (1m)0.01%
EPS NY rev (3m)-1.82%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.01%
Revenue NY rev (1m)0.12%
Revenue NY rev (3m)-0.22%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.24 | ||
| Fwd PE | 14.64 | ||
| P/S | 3.72 | ||
| P/FCF | 16.38 | ||
| P/OCF | 14.05 | ||
| P/B | 3.1 | ||
| P/tB | 26.99 | ||
| EV/EBITDA | 12.14 |
EPS(TTM)4.15
EY6.16%
EPS(NY)4.6
Fwd EY6.83%
FCF(TTM)4.11
FCFY6.1%
OCF(TTM)4.8
OCFY7.12%
SpS18.12
BVpS21.73
TBVpS2.5
PEG (NY)3.57
PEG (5Y)1.5
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.33% | ||
| ROE | 11.5% | ||
| ROCE | 12.64% | ||
| ROIC | 10.03% | ||
| ROICexc | 13.19% | ||
| ROICexgc | 46.87% | ||
| OM | 24.55% | ||
| PM (TTM) | 13.79% | ||
| GM | 56.34% | ||
| FCFM | 22.7% |
ROA(3y)9.32%
ROA(5y)12.89%
ROE(3y)17.06%
ROE(5y)27.35%
ROIC(3y)11.66%
ROIC(5y)15.25%
ROICexc(3y)16.74%
ROICexc(5y)19.65%
ROICexgc(3y)75.27%
ROICexgc(5y)85.91%
ROCE(3y)14.69%
ROCE(5y)19.22%
ROICexcg growth 3Y-27.14%
ROICexcg growth 5Y-3.18%
ROICexc growth 3Y-24.3%
ROICexc growth 5Y7.08%
OM growth 3Y-18.26%
OM growth 5Y7.36%
PM growth 3Y-16.15%
PM growth 5YN/A
GM growth 3Y-5.85%
GM growth 5Y1.6%
F-Score6
Asset Turnover0.46
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.52 | ||
| Debt/FCF | 2.75 | ||
| Debt/EBITDA | 1.96 | ||
| Cap/Depr | 51.64% | ||
| Cap/Sales | 3.77% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 83.11% | ||
| Profit Quality | 164.55% | ||
| Current Ratio | 3.55 | ||
| Quick Ratio | 2.81 | ||
| Altman-Z | 3.97 |
F-Score6
WACC8.04%
ROIC/WACC1.25
Cap/Depr(3y)40.46%
Cap/Depr(5y)40.59%
Cap/Sales(3y)3.27%
Cap/Sales(5y)3.37%
Profit Quality(3y)165.37%
Profit Quality(5y)135.66%
High Growth Momentum
Growth
EPS 1Y (TTM)4.8%
EPS 3Y-21.36%
EPS 5Y10.83%
EPS Q2Q%1.89%
EPS Next Y4.54%
EPS Next 2Y6.23%
EPS Next 3Y7.63%
EPS Next 5Y5.71%
Revenue 1Y (TTM)1.29%
Revenue growth 3Y-10.56%
Revenue growth 5Y3.66%
Sales Q2Q%1.23%
Revenue Next Year1.37%
Revenue Next 2Y3.11%
Revenue Next 3Y3.83%
Revenue Next 5Y4.75%
EBIT growth 1Y7.45%
EBIT growth 3Y-26.89%
EBIT growth 5Y11.29%
EBIT Next Year13.14%
EBIT Next 3Y7.97%
EBIT Next 5Y6.92%
FCF growth 1Y10.21%
FCF growth 3Y-19.16%
FCF growth 5Y16.4%
OCF growth 1Y11.23%
OCF growth 3Y-17.99%
OCF growth 5Y14.62%